| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $367.3M | +14.8% |
| Cost of Revenue | $50.1M | +13.9% |
| Gross Profit | $317.1M | +14.9% |
| R&D Expense | $63.3M | +26.6% |
| SG&A Expense | $82.7M | +60.2% |
| Operating Income | $27.9M | -50.1% |
| Interest Expense | $3.6M | -59.1% |
| Pre-tax Income | $24.5M | -44.4% |
| Income Tax | -$44.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $349.3M | +458.0% |
| Accounts Receivable | $220.9M | -2.5% |
| Current Assets | $581.7M | +95.0% |
| Total Assets | $678.4M | +112.1% |
| Current Liabilities | $204.2M | +3.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $221.1M | -24.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $115.9M | +410.3% |
| Capital Expenditures | $871K | +58.9% |
| Investing Cash Flow | -$10.2M | -151.9% |
| Financing Cash Flow | $181.4M | +7505.2% |
| Free Cash Flow | $115.0M | +419.0% |
| -845.6% |
| Net Income | $68.7M | +80.3% |
| EPS (Basic) | $2.85 | -33.1% |
| EPS (Diluted) | $2.56 | +80.3% |
| Stockholders' Equity |
| $457.3M |
| +1537.4% |